(HIMS) Hims Hers Health - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4330001060

HIMS: Telehealth, Wellness Products, Skincare, Sexual Health, Haircare

Hims & Hers Health, Inc. operates a telehealth platform connecting consumers to licensed healthcare professionals across the United States, the United Kingdom, and internationally. The company offers a range of curated health and wellness products, including prescription and non-prescription options, available for direct purchase via its websites and mobile app. Services include recurring prescription medication, ongoing care from healthcare providers, and over-the-counter products spanning categories such as general wellness, sexual health, skincare, and hair care. Its non-prescription offerings include melatonin and biotin for wellness; moisturizers, serums, and sunscreens for skincare; condoms, lubricants, and vibrators for sexual health; and shampoos, conditioners, and minoxidil-based treatments for hair care. The company also provides medical consultation and post-consultation support, along with wholesale distribution of its health and wellness products.

Based in San Francisco, California, Hims & Hers Health, Inc. has established itself as a key player in the telehealth and direct-to-consumer health products market. Its platform integrates virtual consultations with licensed professionals, enabling consumers to access personalized healthcare solutions. The companys product portfolio is designed to address a broad spectrum of health and wellness needs, with a focus on convenience, affordability, and accessibility. By leveraging technology to streamline healthcare delivery, Hims & Hers Health, Inc. aims to improve consumer access to essential health and wellness services and products.

3-Month Forecast: Based on , HIMS is trading near its SMA 20 (28.11) and SMA 50 (36.53), with a last price of 28.14. The SMA 200 (26.64) indicates potential support, while the ATR (3.09) suggests moderate volatility. From a perspective, the companys high P/E (51.38) and forward P/E (45.66) reflect market expectations for growth, though the P/S ratio (4.10) indicates premium valuation relative to sales. Over the next three months, HIMS may experience price consolidation near its SMA 20 and SMA 50 levels, with potential upside driven by earnings performance or positive catalysts.

Additional Sources for HIMS Stock

HIMS Stock Overview

Market Cap in USD 6,370m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Health Care Services
IPO / Inception 2019-09-13

HIMS Stock Ratings

Growth Rating 56.1
Fundamental 81.3
Dividend Rating 0.0
Rel. Strength 160
Analysts 3.43/5
Fair Price Momentum 29.73 USD
Fair Price DCF 5.70 USD

HIMS Dividends

No Dividends Paid

HIMS Growth Ratios

Growth Correlation 3m -83.3%
Growth Correlation 12m 78.9%
Growth Correlation 5y 31.8%
CAGR 5y 27.15%
CAGR/Max DD 5y 0.31
Sharpe Ratio 12m 1.58
Alpha 136.38
Beta 3.072
Volatility 133.48%
Current Volume 36974k
Average Volume 20d 21315.8k
What is the price of HIMS stocks?
As of May 01, 2025, the stock is trading at USD 33.10 with a total of 36,974,038 shares traded.
Over the past week, the price has changed by +23.92%, over one month by +12.01%, over three months by -11.21% and over the past year by +164.17%.
Is Hims Hers Health a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Hims Hers Health (NYSE:HIMS) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 81.32 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIMS as of May 2025 is 29.73. This means that HIMS is currently overvalued and has a potential downside of -10.18%.
Is HIMS a buy, sell or hold?
Hims Hers Health has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold HIMS.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 7
  • Sell: 1
  • Strong Sell: 1
What are the forecast for HIMS stock price target?
According to ValueRays Forecast Model, HIMS Hims Hers Health will be worth about 35.7 in May 2026. The stock is currently trading at 33.10. This means that the stock has a potential upside of +7.79%.
Issuer Forecast Upside
Wallstreet Target Price 44.7 35%
Analysts Target Price 44.7 35%
ValueRay Target Price 35.7 7.8%